# Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

> **NCT05766839** · PHASE2 · RECRUITING · sponsor: **Vifor Pharma, Inc.** · enrollment: 32 (estimated)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** Patiromer

## Key facts

- **NCT ID:** NCT05766839
- **Lead sponsor:** Vifor Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-06
- **Primary completion:** 2029-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05766839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05766839, "Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT05766839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*